Long-term outcomes after low power, slower movement versus high power, faster movement irrigated-tip catheter ablation for atrial fibrillation

Published:August 06, 2019DOI:


      High power, shorter duration (HPSD) ablation strategies have been advocated to increase efficacy and minimize posterior wall deep tissue thermal injury during atrial fibrillation (AF) ablation.


      The purpose of this study was to determine the long-term outcomes of arrhythmia-free survival from AF and atrial flutter (AFL) between HPSD and low power, longer duration (LPLD) ablation strategies.


      Of a total of 1333 first time AF ablation procedures with 3 years of follow-up, propensity-matched populations for baseline risk factors were created, comprising 402 patients treated with LPLD ablation (30 W for 5 seconds: posterior wall; 30 W for 10–20 seconds: anterior wall) and 402 patients treated with HPSD ablation (50 W for 2–3 seconds: posterior wall; 50 W for 5–15 seconds: anterior wall). AF/AFL outcomes after a 90-day blanking period were assessed.


      HPSD ablation was associated with shorter procedure and fluoroscopy times (P < .0001 for both). The recurrence of AF at 1 year (12.9% vs 16.2%; P = .19) and 3 years (26.5% vs 30.7%; P = .23) was similar between LPLD and HPSD groups. AFL was higher at 1 year (7.2% vs 11.2%; P = .03) and 3 years (16.1% vs 21.8%; P = .06; P = .04 after multivariate adjustment) with HPSD ablation. Patients who underwent an LPLD approach had lower rates of need for repeat ablation (21% vs 30%; P = .002).


      Long-term freedom from AF rates were not significantly different between both approaches. An HPSD ablation strategy compared with an LPLD approach was associated with an increased risk of AFL and need for repeat ablation but with lowered procedure times.


      To read this article in full you will need to make a payment


      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Mark D.B.
        • Anstrom K.J.
        • Sheng S.
        • et al.
        Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial.
        JAMA. 2019; 321: 1275-1285
        • Packer D.L.
        • Mark D.B.
        • Robb R.A.
        • et al.
        Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial.
        JAMA. 2019; 321: 1261-1274
        • Calkins H.
        • Hindricks G.
        • Cappato R.
        • et al.
        2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.
        Heart Rhythm. 2017; 14: e275-e444
        • Bunch T.J.
        • May H.T.
        • Crandall B.G.
        • et al.
        Intracardiac ultrasound for esophageal anatomic assessment and localization during left atrial ablation for atrial fibrillation.
        J Cardiovasc Electrophysiol. 2013; 24: 33-39
        • Bunch T.J.
        • Day J.D.
        Novel ablative approach for atrial fibrillation to decrease risk of esophageal injury.
        Heart Rhythm. 2008; 5: 624-627
        • Bunch T.J.
        • Day J.D.
        • Packer D.L.
        Insights into energy delivery to myocardial tissue during radiofrequency ablation through application of the first law of thermodynamics.
        J Cardiovasc Electrophysiol. 2009; 20: 461-465
        • Winkle R.A.
        • Moskovitz R.
        • Hardwin Mead R.
        • et al.
        Atrial fibrillation ablation using very short duration 50 W ablations and contact force sensing catheters.
        J Interv Card Electrophysiol. 2018; 52: 1-8
        • Nilsson B.
        • Chen X.
        • Pehrson S.
        • Svendsen J.H.
        The effectiveness of a high output/short duration radiofrequency current application technique in segmental pulmonary vein isolation for atrial fibrillation.
        Europace. 2006; 8: 962-965
        • Winkle R.A.
        • Mohanty S.
        • Patrawala R.A.
        • et al.
        Low complication rates using high power (45-50 W) for short duration for atrial fibrillation ablations.
        Heart Rhythm. 2019; 16: 165-169
        • Baher A.
        • Kheirkhahan M.
        • Rechenmacher S.J.
        • et al.
        High-power radiofrequency catheter ablation of atrial fibrillation: using late gadolinium enhancement magnetic resonance imaging as a novel index of esophageal injury.
        JACC Clin Electrophysiol. 2018; 4: 1583-1594
        • Dhillon G.
        • Ahsan S.
        • Honarbakhsh S.
        • et al.
        A multicentered evaluation of ablation at higher power guided by ablation index: establishing ablation targets for pulmonary vein isolation.
        J Cardiovasc Electrophysiol. 2019; 30: 357-365
        • Kawaji T.
        • Hojo S.
        • Kushiyama A.
        • et al.
        Limitations of lesion quality estimated by ablation index: an in vitro study.
        J Cardiovasc Electrophysiol. 2019; 30: 926-933